Noninvasive continuous positive airway pressure delivered by helmet in hematological malignancy patients with hypoxemic acute respiratory failure
To compare the efficacy of early administration of noninvasive continuous positive airway pressure (nCPAP) delivered by the helmet vs. face mask to treat hematological malignancy patients with fever, pulmonary infiltrates, and hypoxemic acute respiratory failure. Prospective clinical study with hist...
Gespeichert in:
| Veröffentlicht in: | Intensive care medicine 2004, Vol.30 (1), p.147-150 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 150 |
|---|---|
| container_issue | 1 |
| container_start_page | 147 |
| container_title | Intensive care medicine |
| container_volume | 30 |
| creator | PRINCIPI, Tiziana PANTANETTI, Simona CATANI, Francesca ELISEI, Daniele GABBANELLI, Vincenzo PELAIA, Paolo LEONI, Pietro |
| description | To compare the efficacy of early administration of noninvasive continuous positive airway pressure (nCPAP) delivered by the helmet vs. face mask to treat hematological malignancy patients with fever, pulmonary infiltrates, and hypoxemic acute respiratory failure.
Prospective clinical study with historical matched controls in the hematology department of a university hospital.
Seventeen hematological malignancy patients with hypoxemic acute respiratory failure defined as: moderate to severe dyspnea, tachypnea (>30-35 breaths/min), use of accessory muscles and paradoxical abdominal motion, and PaO2/FIO2 ratio less than 200. Each patient was treated with nCPAP by helmet outside the ICU in the hematological ward. Arterial oxygen saturation, heart rate, respiratory rate, and blood pressure were monitored to identify early nCPAP failure. Seventeen historical-matched controls treated in the same department with face mask CPAP were selected as control population; matching criteria were age, sex, diagnosis, and PaO2/FIO2 ratio. Primary end-points were improvement in gas exchanges and the need for endotracheal intubation.
Oxygenation improved in all patients after nCPAP. No patient failed helmet nCPAP because of intolerance while eigh patients in the mask group did so. nCPAP could be applied continuously for a longer period of time in the helmet group (28.44+/-0.20 vs. 7.5+/-0.45 h).
Early nCPAP with helmet improves oxygenation in selected immunosuppressed patients with hypoxemic acute respiratory failure. Tolerance of helmet nCPAP seems better than that of nCPAP delivered by mask. |
| doi_str_mv | 10.1007/s00134-003-2056-9 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_216207698</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A147222781</galeid><sourcerecordid>A147222781</sourcerecordid><originalsourceid>FETCH-LOGICAL-c502t-6d1f542f2cba9e56cce2b8b9fc14df4e02062765bf4bd88c0a32374adabdc1db3</originalsourceid><addsrcrecordid>eNptksuKFDEUhoMoTjv6AG4kKC5rzK1uy2EYLzDoRtchlZx0Z6hKyiQ1Yz2Gb2yKbhiEJouEw_efw8n_I_SWkitKSPspEUK5qAjhFSN1U_XP0I4KzirKePcc7QgXrBKNYBfoVUr3hW6bmr5EF1TUPRd1u0N_vwfv_INK7gGwDj47v4Ql4Tkkl7eacvFRrXiOkNISARsYSzmCwcOKDzBOkLHz5TWpHMawd1qNeFKj23vldRGq7MDnhB9dPuDDOoc_MDmNlV4y4NJ1drEo44qtcmOZ8Bq9sGpM8OZ0X6Jfn29_3nyt7n58-XZzfVfpmrBcNYbaWjDL9KB6qButgQ3d0FtNhbECCCMNK-sOVgym6zRRnPFWKKMGo6kZ-CV6f-w7x_B7gZTlfViiLyMlow0jbdN3BfpwhPZqBOm8DTkqPbmk5TUVLWOs7WihqjPUHjxENQYP1pXyf_zVGb4cs33NWQE9CnQMKUWwco5uUnGVlMgtCvIYBVmiILcoyL5o3p32W4YJzJPi5H0BPp4AlYppNha_XHriasGbjfsHX6m_PA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216207698</pqid></control><display><type>article</type><title>Noninvasive continuous positive airway pressure delivered by helmet in hematological malignancy patients with hypoxemic acute respiratory failure</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>PRINCIPI, Tiziana ; PANTANETTI, Simona ; CATANI, Francesca ; ELISEI, Daniele ; GABBANELLI, Vincenzo ; PELAIA, Paolo ; LEONI, Pietro</creator><creatorcontrib>PRINCIPI, Tiziana ; PANTANETTI, Simona ; CATANI, Francesca ; ELISEI, Daniele ; GABBANELLI, Vincenzo ; PELAIA, Paolo ; LEONI, Pietro</creatorcontrib><description>To compare the efficacy of early administration of noninvasive continuous positive airway pressure (nCPAP) delivered by the helmet vs. face mask to treat hematological malignancy patients with fever, pulmonary infiltrates, and hypoxemic acute respiratory failure.
Prospective clinical study with historical matched controls in the hematology department of a university hospital.
Seventeen hematological malignancy patients with hypoxemic acute respiratory failure defined as: moderate to severe dyspnea, tachypnea (>30-35 breaths/min), use of accessory muscles and paradoxical abdominal motion, and PaO2/FIO2 ratio less than 200. Each patient was treated with nCPAP by helmet outside the ICU in the hematological ward. Arterial oxygen saturation, heart rate, respiratory rate, and blood pressure were monitored to identify early nCPAP failure. Seventeen historical-matched controls treated in the same department with face mask CPAP were selected as control population; matching criteria were age, sex, diagnosis, and PaO2/FIO2 ratio. Primary end-points were improvement in gas exchanges and the need for endotracheal intubation.
Oxygenation improved in all patients after nCPAP. No patient failed helmet nCPAP because of intolerance while eigh patients in the mask group did so. nCPAP could be applied continuously for a longer period of time in the helmet group (28.44+/-0.20 vs. 7.5+/-0.45 h).
Early nCPAP with helmet improves oxygenation in selected immunosuppressed patients with hypoxemic acute respiratory failure. Tolerance of helmet nCPAP seems better than that of nCPAP delivered by mask.</description><identifier>ISSN: 0342-4642</identifier><identifier>EISSN: 1432-1238</identifier><identifier>DOI: 10.1007/s00134-003-2056-9</identifier><identifier>PMID: 14593457</identifier><identifier>CODEN: ICMED9</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Acute Disease ; Acute respiratory distress syndrome ; Adult ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Care and treatment ; Continuous positive airway pressure ; Continuous Positive Airway Pressure - instrumentation ; Continuous Positive Airway Pressure - methods ; Continuous Positive Airway Pressure - standards ; Equipment Design ; Female ; Head Protective Devices - standards ; Hematologic Neoplasms - complications ; Hospitals, University ; Humans ; Hypoxia ; Hypoxia - etiology ; Hypoxia - mortality ; Hypoxia - therapy ; Immune Tolerance ; Intensive care medicine ; Italy - epidemiology ; Male ; Masks - adverse effects ; Masks - standards ; Medical sciences ; Middle Aged ; Pilot Projects ; Proportional Hazards Models ; Prospective Studies ; Respiratory Insufficiency - etiology ; Respiratory Insufficiency - mortality ; Respiratory Insufficiency - therapy ; Risk Factors ; Severity of Illness Index ; Survival Analysis ; Treatment Outcome</subject><ispartof>Intensive care medicine, 2004, Vol.30 (1), p.147-150</ispartof><rights>2004 INIST-CNRS</rights><rights>COPYRIGHT 2004 Springer</rights><rights>Copyright Springer-Verlag 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c502t-6d1f542f2cba9e56cce2b8b9fc14df4e02062765bf4bd88c0a32374adabdc1db3</citedby><cites>FETCH-LOGICAL-c502t-6d1f542f2cba9e56cce2b8b9fc14df4e02062765bf4bd88c0a32374adabdc1db3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4021,27921,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15436457$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14593457$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>PRINCIPI, Tiziana</creatorcontrib><creatorcontrib>PANTANETTI, Simona</creatorcontrib><creatorcontrib>CATANI, Francesca</creatorcontrib><creatorcontrib>ELISEI, Daniele</creatorcontrib><creatorcontrib>GABBANELLI, Vincenzo</creatorcontrib><creatorcontrib>PELAIA, Paolo</creatorcontrib><creatorcontrib>LEONI, Pietro</creatorcontrib><title>Noninvasive continuous positive airway pressure delivered by helmet in hematological malignancy patients with hypoxemic acute respiratory failure</title><title>Intensive care medicine</title><addtitle>Intensive Care Med</addtitle><description>To compare the efficacy of early administration of noninvasive continuous positive airway pressure (nCPAP) delivered by the helmet vs. face mask to treat hematological malignancy patients with fever, pulmonary infiltrates, and hypoxemic acute respiratory failure.
Prospective clinical study with historical matched controls in the hematology department of a university hospital.
Seventeen hematological malignancy patients with hypoxemic acute respiratory failure defined as: moderate to severe dyspnea, tachypnea (>30-35 breaths/min), use of accessory muscles and paradoxical abdominal motion, and PaO2/FIO2 ratio less than 200. Each patient was treated with nCPAP by helmet outside the ICU in the hematological ward. Arterial oxygen saturation, heart rate, respiratory rate, and blood pressure were monitored to identify early nCPAP failure. Seventeen historical-matched controls treated in the same department with face mask CPAP were selected as control population; matching criteria were age, sex, diagnosis, and PaO2/FIO2 ratio. Primary end-points were improvement in gas exchanges and the need for endotracheal intubation.
Oxygenation improved in all patients after nCPAP. No patient failed helmet nCPAP because of intolerance while eigh patients in the mask group did so. nCPAP could be applied continuously for a longer period of time in the helmet group (28.44+/-0.20 vs. 7.5+/-0.45 h).
Early nCPAP with helmet improves oxygenation in selected immunosuppressed patients with hypoxemic acute respiratory failure. Tolerance of helmet nCPAP seems better than that of nCPAP delivered by mask.</description><subject>Acute Disease</subject><subject>Acute respiratory distress syndrome</subject><subject>Adult</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Care and treatment</subject><subject>Continuous positive airway pressure</subject><subject>Continuous Positive Airway Pressure - instrumentation</subject><subject>Continuous Positive Airway Pressure - methods</subject><subject>Continuous Positive Airway Pressure - standards</subject><subject>Equipment Design</subject><subject>Female</subject><subject>Head Protective Devices - standards</subject><subject>Hematologic Neoplasms - complications</subject><subject>Hospitals, University</subject><subject>Humans</subject><subject>Hypoxia</subject><subject>Hypoxia - etiology</subject><subject>Hypoxia - mortality</subject><subject>Hypoxia - therapy</subject><subject>Immune Tolerance</subject><subject>Intensive care medicine</subject><subject>Italy - epidemiology</subject><subject>Male</subject><subject>Masks - adverse effects</subject><subject>Masks - standards</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pilot Projects</subject><subject>Proportional Hazards Models</subject><subject>Prospective Studies</subject><subject>Respiratory Insufficiency - etiology</subject><subject>Respiratory Insufficiency - mortality</subject><subject>Respiratory Insufficiency - therapy</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>Survival Analysis</subject><subject>Treatment Outcome</subject><issn>0342-4642</issn><issn>1432-1238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptksuKFDEUhoMoTjv6AG4kKC5rzK1uy2EYLzDoRtchlZx0Z6hKyiQ1Yz2Gb2yKbhiEJouEw_efw8n_I_SWkitKSPspEUK5qAjhFSN1U_XP0I4KzirKePcc7QgXrBKNYBfoVUr3hW6bmr5EF1TUPRd1u0N_vwfv_INK7gGwDj47v4Ql4Tkkl7eacvFRrXiOkNISARsYSzmCwcOKDzBOkLHz5TWpHMawd1qNeFKj23vldRGq7MDnhB9dPuDDOoc_MDmNlV4y4NJ1drEo44qtcmOZ8Bq9sGpM8OZ0X6Jfn29_3nyt7n58-XZzfVfpmrBcNYbaWjDL9KB6qButgQ3d0FtNhbECCCMNK-sOVgym6zRRnPFWKKMGo6kZ-CV6f-w7x_B7gZTlfViiLyMlow0jbdN3BfpwhPZqBOm8DTkqPbmk5TUVLWOs7WihqjPUHjxENQYP1pXyf_zVGb4cs33NWQE9CnQMKUWwco5uUnGVlMgtCvIYBVmiILcoyL5o3p32W4YJzJPi5H0BPp4AlYppNha_XHriasGbjfsHX6m_PA</recordid><startdate>2004</startdate><enddate>2004</enddate><creator>PRINCIPI, Tiziana</creator><creator>PANTANETTI, Simona</creator><creator>CATANI, Francesca</creator><creator>ELISEI, Daniele</creator><creator>GABBANELLI, Vincenzo</creator><creator>PELAIA, Paolo</creator><creator>LEONI, Pietro</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>2004</creationdate><title>Noninvasive continuous positive airway pressure delivered by helmet in hematological malignancy patients with hypoxemic acute respiratory failure</title><author>PRINCIPI, Tiziana ; PANTANETTI, Simona ; CATANI, Francesca ; ELISEI, Daniele ; GABBANELLI, Vincenzo ; PELAIA, Paolo ; LEONI, Pietro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c502t-6d1f542f2cba9e56cce2b8b9fc14df4e02062765bf4bd88c0a32374adabdc1db3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Acute Disease</topic><topic>Acute respiratory distress syndrome</topic><topic>Adult</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Care and treatment</topic><topic>Continuous positive airway pressure</topic><topic>Continuous Positive Airway Pressure - instrumentation</topic><topic>Continuous Positive Airway Pressure - methods</topic><topic>Continuous Positive Airway Pressure - standards</topic><topic>Equipment Design</topic><topic>Female</topic><topic>Head Protective Devices - standards</topic><topic>Hematologic Neoplasms - complications</topic><topic>Hospitals, University</topic><topic>Humans</topic><topic>Hypoxia</topic><topic>Hypoxia - etiology</topic><topic>Hypoxia - mortality</topic><topic>Hypoxia - therapy</topic><topic>Immune Tolerance</topic><topic>Intensive care medicine</topic><topic>Italy - epidemiology</topic><topic>Male</topic><topic>Masks - adverse effects</topic><topic>Masks - standards</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pilot Projects</topic><topic>Proportional Hazards Models</topic><topic>Prospective Studies</topic><topic>Respiratory Insufficiency - etiology</topic><topic>Respiratory Insufficiency - mortality</topic><topic>Respiratory Insufficiency - therapy</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>Survival Analysis</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>PRINCIPI, Tiziana</creatorcontrib><creatorcontrib>PANTANETTI, Simona</creatorcontrib><creatorcontrib>CATANI, Francesca</creatorcontrib><creatorcontrib>ELISEI, Daniele</creatorcontrib><creatorcontrib>GABBANELLI, Vincenzo</creatorcontrib><creatorcontrib>PELAIA, Paolo</creatorcontrib><creatorcontrib>LEONI, Pietro</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Intensive care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>PRINCIPI, Tiziana</au><au>PANTANETTI, Simona</au><au>CATANI, Francesca</au><au>ELISEI, Daniele</au><au>GABBANELLI, Vincenzo</au><au>PELAIA, Paolo</au><au>LEONI, Pietro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Noninvasive continuous positive airway pressure delivered by helmet in hematological malignancy patients with hypoxemic acute respiratory failure</atitle><jtitle>Intensive care medicine</jtitle><addtitle>Intensive Care Med</addtitle><date>2004</date><risdate>2004</risdate><volume>30</volume><issue>1</issue><spage>147</spage><epage>150</epage><pages>147-150</pages><issn>0342-4642</issn><eissn>1432-1238</eissn><coden>ICMED9</coden><abstract>To compare the efficacy of early administration of noninvasive continuous positive airway pressure (nCPAP) delivered by the helmet vs. face mask to treat hematological malignancy patients with fever, pulmonary infiltrates, and hypoxemic acute respiratory failure.
Prospective clinical study with historical matched controls in the hematology department of a university hospital.
Seventeen hematological malignancy patients with hypoxemic acute respiratory failure defined as: moderate to severe dyspnea, tachypnea (>30-35 breaths/min), use of accessory muscles and paradoxical abdominal motion, and PaO2/FIO2 ratio less than 200. Each patient was treated with nCPAP by helmet outside the ICU in the hematological ward. Arterial oxygen saturation, heart rate, respiratory rate, and blood pressure were monitored to identify early nCPAP failure. Seventeen historical-matched controls treated in the same department with face mask CPAP were selected as control population; matching criteria were age, sex, diagnosis, and PaO2/FIO2 ratio. Primary end-points were improvement in gas exchanges and the need for endotracheal intubation.
Oxygenation improved in all patients after nCPAP. No patient failed helmet nCPAP because of intolerance while eigh patients in the mask group did so. nCPAP could be applied continuously for a longer period of time in the helmet group (28.44+/-0.20 vs. 7.5+/-0.45 h).
Early nCPAP with helmet improves oxygenation in selected immunosuppressed patients with hypoxemic acute respiratory failure. Tolerance of helmet nCPAP seems better than that of nCPAP delivered by mask.</abstract><cop>Heidelberg</cop><cop>Berlin</cop><pub>Springer</pub><pmid>14593457</pmid><doi>10.1007/s00134-003-2056-9</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0342-4642 |
| ispartof | Intensive care medicine, 2004, Vol.30 (1), p.147-150 |
| issn | 0342-4642 1432-1238 |
| language | eng |
| recordid | cdi_proquest_journals_216207698 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Acute Disease Acute respiratory distress syndrome Adult Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Care and treatment Continuous positive airway pressure Continuous Positive Airway Pressure - instrumentation Continuous Positive Airway Pressure - methods Continuous Positive Airway Pressure - standards Equipment Design Female Head Protective Devices - standards Hematologic Neoplasms - complications Hospitals, University Humans Hypoxia Hypoxia - etiology Hypoxia - mortality Hypoxia - therapy Immune Tolerance Intensive care medicine Italy - epidemiology Male Masks - adverse effects Masks - standards Medical sciences Middle Aged Pilot Projects Proportional Hazards Models Prospective Studies Respiratory Insufficiency - etiology Respiratory Insufficiency - mortality Respiratory Insufficiency - therapy Risk Factors Severity of Illness Index Survival Analysis Treatment Outcome |
| title | Noninvasive continuous positive airway pressure delivered by helmet in hematological malignancy patients with hypoxemic acute respiratory failure |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T18%3A09%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Noninvasive%20continuous%20positive%20airway%20pressure%20delivered%20by%20helmet%20in%20hematological%20malignancy%20patients%20with%20hypoxemic%20acute%20respiratory%20failure&rft.jtitle=Intensive%20care%20medicine&rft.au=PRINCIPI,%20Tiziana&rft.date=2004&rft.volume=30&rft.issue=1&rft.spage=147&rft.epage=150&rft.pages=147-150&rft.issn=0342-4642&rft.eissn=1432-1238&rft.coden=ICMED9&rft_id=info:doi/10.1007/s00134-003-2056-9&rft_dat=%3Cgale_proqu%3EA147222781%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=216207698&rft_id=info:pmid/14593457&rft_galeid=A147222781&rfr_iscdi=true |